Mental Health Clinics in Upper Saddle River, NJ Accepting Medicare
4 Mental Health Clinics found. Showing 1 - 4
 Rlg Counseling Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 8 Mill Glen Ct, Upper Saddle River, NJ 07458 Phone: 561-305-7220 |
Live Well Center Llc Psychologist - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 8 Birchwood Ct, Upper Saddle River, NJ 07458 Phone: 201-934-9467 |
Therapy Today Llc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 372 E Saddle River Rd, Upper Saddle River, NJ 07458 Phone: 201-893-1255 |
Hidden Gems Aba -nc- Llc Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 600 E Crescent Ave Ste 109, Upper Saddle River, NJ 07458 Phone: 201-500-9915 |
News Archive
Axxam, Cellectis bioresearch partner to offer cell-based assays to Life Science industry
Axxam (Milan), a leading provider of discovery services including assay development for high-throughput screening, and Cellectis bioresearch (Paris), the cell engineering expert, have started a collaboration to offer to the Life Science industry an extensive range of integrated discovery services based on genomic engineering technologies.
Functional connectivity in brain's fatigue network changes in response to cognitive fatigue
Kessler Foundation researchers have demonstrated changes in the functional connectivity within the 'fatigue network' in response to cognitive fatigue.
Raptor partners with Uni Pharma to commercialize Convivia in Taiwan
Raptor Pharmaceutical Corp., announced that it has entered into an exclusive agreement with Uni Pharma Co., Ltd. to commercialize Convivia™, Raptor's proprietary oral formulation of 4-methylpyrazole, in Taiwan.
SANUWAVE receives U.S. patent titled, 'Device for the Application of Acoustic Shock Waves'
SANUWAVE Health, Inc., an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced that the U.S. Patent and Trademark Office (USPTO) has issued the Company patent number 8,088,073, titled "Device for the Application of Acoustic Shock Waves."
Three-drug combination produces better results in multiple myeloma patients
In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team led by investigators from Mayo Clinic.
› Verified 2 days ago